10-K//Annual report
CORTEX PHARMACEUTICALS INC/DE/ 10-K
Accession 0001193125-04-162293
CIK 0000849636operating
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 4:09 PM ET
Size
923.8 KB
Accession
0001193125-04-162293
Documents
- 10-Kd10k.htmPrimary
FORM 10-K FOR CORTEX PHARMACEUTICALS, INC.
- EX-10.79dex1079.htm
AMENDMENT NO. 2 TO THE LEASE AGREEMENT FOR THE COMPANY'S FACILITIES IN IRVINE
- EX-10.80dex1080.htm
FORM OF INCENTIVE/NONQUALIFIED STOCK OPTION AGREEMENT
- EX-10.81dex1081.htm
FORM OF RESTRICTED STOCK AWARD
- EX-10.82dex1082.htm
AMENDMENT TO THE EMPLOYMENT AGREEMENTED DATED MAY 17, 2000 - JAMES H. COLEMAN
- EX-10.83dex1083.htm
AMENDMENT TO THE EMPLOYMENT AGREEMENT DATED JUNE 5, 1995 - GARY A. ROGERS, PH.D.
- EX-23.1dex231.htm
CONSENT OF ERNST & YOUNG LLP
- EX-31.1dex311.htm
SECTION 302 CERTIFICATION BY CHIEF EXECUTIVE OFFICER
- EX-31.2dex312.htm
SECTION 302 CERTIFICATION BY CHIEF FINANCIAL OFFICER
- EX-32dex32.htm
SECTION 906 CERTIFICATION OF CEO AND CFO
Issuer
RespireRx Pharmaceuticals Inc.
CIK 0000849636
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000849636
Filing Metadata
- Form type
- 10-K
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 4:09 PM ET
- Size
- 923.8 KB